SynAct Pharma AB (SYNACT) — Strategic Asset Allocation Index
SynAct Pharma AB (SYNACT) has a Strategic Asset Allocation Index of 0.4% as of June 2023. Strategic assets (PP&E of Skr993.00K plus long-term investments of Skr-) total Skr993.00K, measured against net assets of Skr241.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See SYNACT net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
SynAct Pharma AB Strategic Asset Allocation Index (2021–2022)
This chart shows how SynAct Pharma AB's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of June 2023, the index stands at 0.4%, representing strategic assets of Skr993.00K against net assets of Skr241.50 Million SEK. For live market cap and overall valuation, see SynAct Pharma AB market capitalisation.
Annual Strategic Asset Allocation Index for SynAct Pharma AB (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for SynAct Pharma AB from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See SYNACT total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.7% | Skr2.10 Million | Skr2.10 Million | Skr- | Skr126.52 Million | ▼ -13.6 pp |
| 2021 | 15.2% | Skr3.18 Million | Skr3.18 Million | Skr- | Skr20.87 Million | — |